The table below shows Vir Biotechnology, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$68.56M
$74.20M
$86.18M
$1.62B
$1.10B
$76.37M
Cost of revenue
$26.00K
$845.00K
$2.77M
$146.32M
$65.86M
$0.00
Gross profit
-
-
-
-
-
-
R&D
$455.97M
$506.50M
$579.72M
$474.65M
$448.01M
$302.41M
SG&A
VIR annual revenue (10-K history)
Vir Biotechnology, Inc. reported annual revenue of $68.56M for fiscal year 2025. That is down 7.6% from $74.20M in fiscal 2024. Over the 9 fiscal years shown, annual revenue grew from $2.71M (FY 2017) to $68.56M. Figures come from the company's audited annual reports as filed with the SEC.